JP2024540322A5 - - Google Patents
Info
- Publication number
- JP2024540322A5 JP2024540322A5 JP2024526682A JP2024526682A JP2024540322A5 JP 2024540322 A5 JP2024540322 A5 JP 2024540322A5 JP 2024526682 A JP2024526682 A JP 2024526682A JP 2024526682 A JP2024526682 A JP 2024526682A JP 2024540322 A5 JP2024540322 A5 JP 2024540322A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- cell epitopes
- human
- acid sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275015P | 2021-11-03 | 2021-11-03 | |
| US63/275,015 | 2021-11-03 | ||
| US202263377087P | 2022-09-26 | 2022-09-26 | |
| US63/377,087 | 2022-09-26 | ||
| PCT/EP2022/080679 WO2023079001A1 (en) | 2021-11-03 | 2022-11-03 | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of diseases caused by sars-cov-2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540322A JP2024540322A (ja) | 2024-10-31 |
| JP2024540322A5 true JP2024540322A5 (cg-RX-API-DMAC10.html) | 2025-11-11 |
Family
ID=84365420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526682A Pending JP2024540322A (ja) | 2021-11-03 | 2022-11-03 | SARS-CoV-2によって引き起こされる疾患の予防及び処置に使用するための免疫原性構築物及びワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049910A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4426344A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024540322A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240110821A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022381515A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3235174A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL312539A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024005408A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023079001A1 (cg-RX-API-DMAC10.html) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004215489B2 (en) | 2003-02-25 | 2010-07-15 | Nykode Therapeutics ASA | Modified antibody |
| WO2011161244A1 (en) | 2010-06-25 | 2011-12-29 | Vaccibody As | Homodimeric protein constructs |
| EP3533462A1 (en) | 2011-12-21 | 2019-09-04 | Vaccibody AS | Vaccines against hpv |
| JP2019505512A (ja) | 2016-01-08 | 2019-02-28 | バッシボディ アクスイェ セルスカプ | 治療用抗癌ネオエピトープワクチン |
| CN113631185A (zh) | 2019-02-27 | 2021-11-09 | 尼克塔治疗公司 | 用于治疗癌症的免疫治疗组合 |
| PH12022552164A1 (en) * | 2020-02-19 | 2023-11-29 | United Biomedical Inc | Designer peptides and proteins for the detection, prevention and treatment of coronavirus disease, 2019 (covid-19) |
| US20230218741A1 (en) * | 2020-03-31 | 2023-07-13 | The Children's Hospital Of Philadelphia | Sars-cov-2 vaccines for population-scale immunity |
-
2022
- 2022-11-03 EP EP22813933.3A patent/EP4426344A1/en active Pending
- 2022-11-03 JP JP2024526682A patent/JP2024540322A/ja active Pending
- 2022-11-03 KR KR1020247018623A patent/KR20240110821A/ko active Pending
- 2022-11-03 AU AU2022381515A patent/AU2022381515A1/en active Pending
- 2022-11-03 MX MX2024005408A patent/MX2024005408A/es unknown
- 2022-11-03 IL IL312539A patent/IL312539A/en unknown
- 2022-11-03 US US18/706,648 patent/US20250049910A1/en active Pending
- 2022-11-03 WO PCT/EP2022/080679 patent/WO2023079001A1/en not_active Ceased
- 2022-11-03 CA CA3235174A patent/CA3235174A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Han et al. | IL-15: IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization | |
| ES3064850T3 (en) | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo | |
| JP2023524054A5 (cg-RX-API-DMAC10.html) | ||
| ES2210255T3 (es) | Metodos para mejorar la actividad biologica de quimiocinas. | |
| JP2022017499A (ja) | 治療用抗癌ネオエピトープワクチン | |
| CA2304254A1 (en) | Trimerising module | |
| JP2019123719A (ja) | インターロイキン−10を疾病及び疾患の治療に用いる方法 | |
| JP2013513377A5 (cg-RX-API-DMAC10.html) | ||
| RU2012129208A (ru) | Конъюгаты и композиции для иммунотерапии и противоопухолевого лечения | |
| JP2022541657A5 (cg-RX-API-DMAC10.html) | ||
| JP2020528743A5 (cg-RX-API-DMAC10.html) | ||
| RU2677799C2 (ru) | Модифицированные суперспиральные белки с улучшенными свойствами | |
| WO2008000516B1 (en) | IMPROVED sgp130Fc DIMERS | |
| WO2004026897A1 (ja) | Wt1置換型ペプチド | |
| JP2023528207A5 (cg-RX-API-DMAC10.html) | ||
| WO2011101332A1 (en) | Compositions based on the fibronectin extracellular domain a for the treatment of melanoma | |
| JP2023522588A5 (cg-RX-API-DMAC10.html) | ||
| EP2145898A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| JP2024516613A5 (cg-RX-API-DMAC10.html) | ||
| WO2022141771A1 (zh) | 一种长效化白介素15融合蛋白及其制备方法和应用 | |
| ES2217199T3 (es) | Mutantes de quimioquinas en el tratamiento de la esclerosis multiple. | |
| KR101101004B1 (ko) | 신규한 펩티드 및 그들의 치료 용도 | |
| CN111499762B (zh) | 一种包含PDGFRβ特异性亲和体和TNFα的融合蛋白及其用途 | |
| JP2022513626A5 (cg-RX-API-DMAC10.html) | ||
| TWI905155B (zh) | 包含 il-2蛋白及cd80蛋白片段或其變異體的融合蛋白及其用途 |